# Biomarkers in Predicting Response in Patients With Graft-Versus-Host Disease Undergoing Extracorporeal Photophoresis

> **NCT01324908** · NA · TERMINATED · sponsor: **Vanderbilt-Ingram Cancer Center** · enrollment: 85 (actual)

## Conditions studied

- Graft Versus Host Disease (GVHD)

## Interventions

- **PROCEDURE:** extracorporeal photopheresis
- **OTHER:** laboratory biomarker analysis

## Key facts

- **NCT ID:** NCT01324908
- **Lead sponsor:** Vanderbilt-Ingram Cancer Center
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2011-07
- **Primary completion:** 2017-07-28
- **Final completion:** 2020-11-16
- **Target enrollment:** 85 (ACTUAL)
- **Why stopped:** Low accrual
- **Last updated:** 2021-01-14

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01324908

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01324908, "Biomarkers in Predicting Response in Patients With Graft-Versus-Host Disease Undergoing Extracorporeal Photophoresis". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01324908. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*